SINT earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -0.28. Updated 2026-07-23.
Sintx Technologies (SINT) Research Hub
Sintx Technologies (SINT) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 1.8 USD (-1.10%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.28, market cap 0.00B. This hub links to the full technical, earnings and options research available for SINT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.8 USD (-1.10%) |
| 52-week range | 1.4 USD – 2.23 USD |
| Trend regime | Range |
| 14-day RSI | 58.8 (Bullish) |
| Trailing P/E | -0.28 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for SINT
Covered Call on SINT: how it works, illustrative setup around the real 1.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SINT: how it works, illustrative setup around the real 1.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SINT: how it works, illustrative setup around the real 1.8 USD price, max profit/loss, breakeven and when to use it. Educational.
SINT technical analysis: range, last 1.8 USD, RSI 58.8, 52w range 1.4 USD–2.23 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SINT in?
Sintx Technologies (SINT) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is SINT in an uptrend or downtrend?
As of 2026-09-11, SINT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SINT's trailing P/E ratio?
SINT's trailing P/E is -0.28, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does SINT next report earnings?
SINT is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.69 USD.